Mentions
Extended reach
Total likes
Video views
AI synopsis
Several discussions highlight the practical aspects of implementing the KDIGO guidelines, such as aiming for an SBP of 120-130 mm Hg and referencing key studies like SPRINT. The tone varies from supportive to contemplative, with phrases like 'recommendation' and 'practical achievement,' illustrating a focus on applying these standards in real-world settings. The choice of words underscores both respect for the guidelines and awareness of ongoing debates about their adoption.
Most discussions express support and acknowledgment of the guidelines' importance, with some referencing specific recommendations like blood pressure targets and treatment strategies.
Posts show curiosity and relevance, referencing key trials such as SPRINT and highlighting practical considerations for management, indicating moderate interest.
The focus on summaries, commentaries, and specific details like SBP targets reflect a moderate level of engagement and contemplation of the material.
They seem to recognize the guidelines' significance in clinical practice, as evidenced by references to adoption challenges and practice implications.
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. https://t.co/0aIaVuGNSV #CardioTwitter https://t.co/kssIDYaPVW
Marvin González, from UNAN-León, Nicaragua. No COI. I am happy to participate in this journal club: KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. #NephJC
23) Re #bloodpressure mgt in glomerular disease, while target SBP in most adult pts is <120mmHg using standardized office BP measurement, this has not been validated in GN. In practicality, shoot for SBP 120-130 in most pts with glomerular diseases.
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease – via @Kidney_Int https://t.co/P72C91EEFx
16) @goKDIGO Recommendation 3.6.3: KDIGO recommends starting #RASi (ACEi or #ARB) for people with #CKD and moderately-to severely increased #albuminuria (G1–G4, A2 and A3) with diabetes (1B) #VisualGraphic from @Dilushiwijay @NephJC #Nephpearls
Como siempre, aquí les dejamos las fuentes bibliográficas para puedan consultarlo‼️ Bibliografía:
Prof Johannes Mann presents the FLOW study results demonstrating the nephroprotective effects of Semaglutide in 3533 chronic kidney disease patients, emphasizing recent advances in managing blood pressure in CKD.
Prof Johannes Mann and Prof Dasgupta discuss the advantages and disadvantages of the 2021 KDIGO blood pressure guidelines for CKD patients, focusing on lowering BP below 120 mmHg and its implications for routine…
RT @ckd_ce: 8b) Referral to providers/programs (psychologists, renal dietitians or accredited nutritionists, pharmacists, physical & occupa…
16) @goKDIGO Recommendation 3.6.3: KDIGO recommends starting #RASi (ACEi or #ARB) for people with #CKD and moderately-to severely increased #albuminuria (G1–G4, A2 and A3) with diabetes (1B) #VisualGraphic from @Dilushiwijay @NephJC #Nephpearls
8b) Referral to providers/programs (psychologists, renal dietitians or accredited nutritionists, pharmacists, physical & occupational tx,
16) @goKDIGO Recommendation 3.6.3: KDIGO recommends starting #RASi (ACEi or #ARB) for people with #CKD and moderately-to severely increased #albuminuria (G1–G4, A2 and A3) with diabetes (1B) #VisualGraphic from @Dilushiwijay @NephJC #Nephpearls
8b) Referral to providers/programs (psychologists, renal dietitians or accredited nutritionists, pharmacists, physical & occupational tx,
SBPは120mmHg未満を推奨 KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Diseaseの推奨のまま ACCORD/SPRINT trial以上のエビデンスは今のところないと
34) Target #SBP < 120 mm Hg has not been validated in #GN. In practicality, we are able to achieve an SBP 120-130 mm Hg in most patients with #glomerular disease https://t.co/BnrmRE2WMB https://t.co/SEDWadsua9
RT @ckd_ce: 12a) Based on the SPRINT trial, the @goKDIGO guidelines gave a Level 1B recommendation that adults with high #BP and #CKD be tr…
12a) Based on the SPRINT trial, the @goKDIGO guidelines gave a Level 1B recommendation that adults with high #BP and #CKD be treated with a target systolic blood pressure (SBP) of <120 mm Hg, when tolerated, using standardized office BP measurement.
RT @nefromania: Como siempre, aquí les dejamos las fuentes bibliográficas para puedan consultarlo‼️ Bibliografía:
Como siempre, aquí les dejamos las fuentes bibliográficas para puedan consultarlo‼️ Bibliografía:
23) Re #bloodpressure mgt in glomerular disease, while target SBP in most adult pts is <120mmHg using standardized office BP measurement, this has not been validated in GN. In practicality, shoot for SBP 120-130 in most pts with glomerular diseases.
This commentary from @SpringerCurRpts has been popular among #nephrologists recently https://t.co/w6YRVvxOAr #ReadbyQxMD #NephJC https://t.co/EXSmwFIthi
RT @VanessitaDeniz: Commentary on the #KDIGO 2021 Clinical Practice #Guideline for the Management of #BloodPressure in CKD. https://t.co/PZ…
Commentary on the #KDIGO 2021 Clinical Practice #Guideline for the Management of #BloodPressure in CKD. https://t.co/PZ03PkHXak
Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD https://t.co/P7Vmdv207t
Johannes F E Mann: Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD https://t.co/PNgjy8pSRi
RT @toki_wo_koe: 自宅待機中で、KDIGOの特に降圧管理のところをちょっと攻めてみたりして。 KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chro…
自宅待機中で、KDIGOの特に降圧管理のところをちょっと攻めてみたりして。 KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease https://t.co/shU9DmiJ38 (自身の結構伸びたtweetを掘り起こしてみたり。) https://t.co/eYGaqz7qdU https://t.co/ETO699StHK
RT @DrRaniKhatib: KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. https://t.co/0aIa…
RT @DrRaniKhatib: KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. https://t.co/0aIa…
RT @DrRaniKhatib: KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. https://t.co/0aIa…
RT @DrRaniKhatib: KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. https://t.co/0aIa…
RT @DrRaniKhatib: KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. https://t.co/0aIa…
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. https://t.co/0aIaVuGNSV #CardioTwitter https://t.co/kssIDYaPVW
Marvin González, from UNAN-León, Nicaragua. No COI. I am happy to participate in this journal club: KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. #NephJC
KDIGO 2021 Clinical Practice Guideline: For the Management of Blood Pressure in Chronic Kidney Disease https://t.co/JEcJLWCQNs https://t.co/RqbiT4ZpLS
RT @EvidenceStock: Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney D…
Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease 慢性腎臓病患者における血圧管理方針 ACEiまたはARB、CCB、サイアザイド系利尿薬を用いて、SBP<120mmHg、DBP<90mmHgを目標に管理 https://t.co/e2vMSQJy2n https://t.co/qVhdNxSjXB
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease https://t.co/5xuyeW80jQ
RT @mikesbkelly: Which is more likely to be adopted in practice, targeting a SBP<120 or measuring BP w/ "standardized BP measurement"? @ac…
Which is more likely to be adopted in practice, targeting a SBP<120 or measuring BP w/ "standardized BP measurement"? @accpcardprn @accpambuprn @AFPJournal https://t.co/BUeAqRtGf4
Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease https://t.co/R06X1eXRmZ
Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease https://t.co/FZqcp486lK https://t.co/MdgkLxcBs1
Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease https://t.co/DDZNrSTIMM
RT @Links_Medicus: KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease – via @Kidney_Int…
RT @Links_Medicus: KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease – via @Kidney_Int…
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease – via @Kidney_Int https://t.co/P72C91EEFx
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease https://t.co/VWLffox1Z3 @goKDIGO
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease - Kidney International https://t.co/maAv0Mz8dR
DF
MD
CC
DC
NM
ST
CM
じ
YE
D
L
QJ
SS
BD
DM
CB
向
と
UC
EA
HT
JR
B
DA
山
E
B
J
MK
MM
R
CT
JR
A
AJ
LA